{"id":"https://openalex.org/W2013330935","doi":"https://doi.org/10.1001/jama.2014.1403","title":"Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation","display_name":"Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation","publication_year":2014,"publication_date":"2014-03-18","ids":{"openalex":"https://openalex.org/W2013330935","doi":"https://doi.org/10.1001/jama.2014.1403","mag":"2013330935","pmid":"https://pubmed.ncbi.nlm.nih.gov/24643605"},"language":"en","primary_location":{"id":"doi:10.1001/jama.2014.1403","doi":"https://doi.org/10.1001/jama.2014.1403","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2014.1403","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113655070","display_name":"Karsten Bruins Slot","orcid":"https://orcid.org/0000-0003-4372-7253","observed_orcids":["https://orcid.org/0000-0003-4372-7253"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Karsten M. H. Bruins Slot","raw_affiliation_strings":["Department of Internal Medicine, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108709960","display_name":"Eivind Berge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Eivind Berge","raw_affiliation_strings":["Department of Internal Medicine, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1281400175"],"apc_list":null,"apc_paid":null,"fwci":1.1145,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.79815015,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"311","issue":"11","first_page":"1150","last_page":"1150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":1.0},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.996999979019165},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.984000027179718},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.9800000190734863},{"id":"https://openalex.org/keywords/thromboembolism","display_name":"thromboembolism","score":0.8700000047683716},{"id":"https://openalex.org/keywords/intracranial-hemorrhage","display_name":"intracranial hemorrhage","score":0.9129999876022339},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.9319999814033508},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.6069999933242798},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.75},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9340000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9695602655410767},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.89274001121521},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8876917362213135},{"id":"https://openalex.org/C2776704044","wikidata":"https://www.wikidata.org/wiki/Q2852541","display_name":"Vitamin K antagonist","level":4,"score":0.6840825080871582},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.6698933243751526},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6558784246444702},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5589902997016907},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.5157980918884277},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.46460431814193726},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D004617","descriptor_name":"Embolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014812","descriptor_name":"Vitamin K","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020766","descriptor_name":"Intracranial Embolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.2014.1403","doi":"https://doi.org/10.1001/jama.2014.1403","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2014.1403","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:24643605","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24643605","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W2069451418","https://openalex.org/W2761632289","https://openalex.org/W3030533492"],"related_works":["https://openalex.org/W4232266734","https://openalex.org/W2977147713","https://openalex.org/W2567124247","https://openalex.org/W4390570490","https://openalex.org/W2761632289","https://openalex.org/W4246377756","https://openalex.org/W3092653805","https://openalex.org/W2886125097","https://openalex.org/W2061044688","https://openalex.org/W2380764376"],"abstract_inverted_index":{"CLINICAL":[0],"QUESTION:":[1],"Is":[2],"treatment":[3],"with":[4,9,15,31,37,44,57,65,74,81],"factor":[5,39],"Xa":[6,40,61,77],"inhibitors":[7,41,62,78],"associated":[8,43,64,80],"better":[10],"efficacy":[11],"and":[12,50,71,96],"safety":[13],"compared":[14,73],"the":[16,93,97],"vitamin":[17],"K":[18],"antagonist":[19],"warfarin":[20],"for":[21],"preventing":[22],"strokes":[23],"or":[24],"other":[25,51],"systemic":[26,52],"embolic":[27,53],"events":[28,54],"in":[29,55,84,103],"patients":[30,56],"atrial":[32,58],"fibrillation?":[33],"BOTTOM":[34],"LINE:":[35],"Compared":[36],"warfarin,":[38],"are":[42],"a":[45,82,104],"lower":[46,66],"risk":[47],"of":[48,68],"stroke":[49],"fibrillation.":[59],"Factor":[60,76],"were":[63,79],"rates":[67],"intracranial":[69],"hemorrhage":[70],"mortality":[72],"warfarin.":[75],"reduction":[83,98],"major":[85],"bleeding":[86],"events,":[87],"but":[88],"there":[89],"was":[90,99],"heterogeneity":[91],"between":[92],"included":[94],"studies,":[95],"not":[100],"statistically":[101],"significant":[102],"prespecified":[105],"sensitivity":[106],"analysis.":[107]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}